Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
Enric Monreal(Hospital Universitario Ramón y Cajal), Luisa María Villar(Evidence (Italy)), Jaime Masjuán(Universidad de Alcalá), Paulette Esperanza Walo-Delgado(Universidad de Alcalá), José Ignacio Fernández-Velasco(Hospital Universitario Ramón y Cajal), Inmaculada Toboso(Instituto Cajal), Noelia Villarrubia(Universidad de Alcalá), Lucienne Costa‐Frossard(Universidad de Alcalá), Javier Zamora(Universidad de Alcalá), José C. Álvarez‐Cermeño(Hospital Universitario Ramón y Cajal), Paloma Lapuente(Instituto Cajal), Mercedes Espiño(Hospital Universitario Ramón y Cajal), Daniel Lourido(Universidad de Alcalá)
Cited by 40
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study
|European Journal of Neurology|2020|385